2020 MELANOMA - What is the Correct Choice for First Line Therapy for BRAF Positive Metastatic Melanoma
GRACE is excited to bring you a new series on current updates in Melanoma Treatment.
Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow, MD Chief of Melanoma Service at Memorial Sloan Kettering, and Sanjiv Agarwala, MD, Professor of Medical Oncology and Hematology at Temple University School of Medicine in Easton, PA joined GRACE to discuss current updates in treatment for Melanoma.
In this video, Dr. Postow discusses first line therapy for BRAF positive metastatic melanoma.
A huge thank you to Merck for sponsoring this program.
To join the conversation, visit https://cancergrace.org/forum.
Video Language:
